| Integrated approaches for precision oncology in colorectal cancer: The more you know, the better P Andrei, P Battuello, G Grasso, E Rovera, N Tesio, A Bardelli Seminars in cancer biology 84, 199-213, 2022 | 44 | 2022 |
| Targeting the DNA damage response pathways and replication stress in colorectal cancer E Durinikova, NM Reilly, K Buzo, E Mariella, R Chilà, A Lorenzato, ... Clinical Cancer Research 28 (17), 3874-3889, 2022 | 19 | 2022 |
| P336: a chemotranscriptomic screening identifies the reversal of glucocorticoid resistance in notch1 mutated T-ALL L Pagliaro, LM Dalla Tor, V Federica, P Andrei, L Monica, S Kleissle, ... HemaSphere 6, 236-237, 2022 | 1 | 2022 |
| Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer E Mariella, G Grasso, M Miotto, K Buzo, NM Reilly, P Andrei, PP Vitiello, ... Molecular Oncology, 2024 | | 2024 |
| The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia A Montanaro, A D'Antuono, LM Dalla Tor, P Andrei, F Cavazzini, ... Blood 142, 118, 2023 | | 2023 |
| Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer G Grasso, E Marriella, M Miotto, K Buzo, NM Reilly, P Andrei, PP Vitiello, ... Cancer Research 83 (8_Supplement), LB058-LB058, 2023 | | 2023 |
| Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia A Montanaro, A D'Antuono, L Moron Dalla Tor, P Andrei, A Ciringione, ... Blood 140 (Supplement 1), 3130-3131, 2022 | | 2022 |
| ALKBH3 deficiency and liability to alkylating agents in CRC models PP Vitiello, E Mariella, P Andrei, V Amodio, G Germano, A Lorenzato, ... Cancer Research 82 (12_Supplement), 4034-4034, 2022 | | 2022 |
| SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL L Pagliaro, L Dalla Tor, L Monica, P Andrei, F Vento, E Simoncini, ... HAEMATOLOGICA 107, 19-19, 2022 | | 2022 |
